Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Dec;57(1):2445191.
doi: 10.1080/07853890.2024.2445191. Epub 2024 Dec 26.

Neuropsychiatric manifestations of sarcoidosis

Affiliations
Review

Neuropsychiatric manifestations of sarcoidosis

Claudio Tana et al. Ann Med. 2025 Dec.

Abstract

Background: There has been significant progress in understanding neurosarcoidosis (NS) as a distinct disorder, which encompasses a heterogeneous group of clinical and radiological alterations which can affect patients with systemic sarcoidosis or manifest isolated.

Rationale and aim of the study: The healthcare challenges posed by NS and sarcoidosis in general extend beyond their physical symptoms and can include a variety of psychosocial factors, therefore the recognition of main neuropsychiatric symptoms can be useful to approach patients with NS. Methods: For this purpose, databases such as Pubmed, Medline and Pubmed Central (PMC) have been searched.

Results: A correct diagnosis of NS is established by the combination of clinical picture, imaging features and the histopathological finding of non-caseating and non-necrotizing granulomas. After analyzing the current literature, there is a need for specific, case-control, cohort and clinical trials on the psychiatric manifestations of sarcoidosis, because the evaluation of psychological distress (in terms of emotional suffering e.g. anxiety or depression) is often underestimated.

Discussion and conclusion: Exploring the neuropsychiatric manifestations of sarcoidosis is useful to raise awareness of this condition among clinicians and to establish a holistic management, which includes both physical and psychological aspects.

Keywords: Sarcoidosis; anxiety; depression; disease; fatigue; headache; neuropathy; pain.

PubMed Disclaimer

Conflict of interest statement

Dr. Claudio Tana is the Section Editor of the Primary Care section of Annals of Medicine.

Figures

Figure 1.
Figure 1.
Common causes of pain in sarcoidosis patients. Created with BioRender.

Similar articles

References

    1. Voortman M, Drent M, Stern BJ.. Neurosarcoidosis and neurologic complications of sarcoidosis treatment. Clin Chest Med. 2024;45(1):91–103. doi: 10.1016/j.ccm.2023.08.005. - DOI - PubMed
    1. Kidd DP. Neurosarcoidosis. J Neurol. 2024;271(2):1047–1055. doi: 10.1007/s00415-023-12046-w. - DOI - PubMed
    1. Sharp M, Brown T, Chen E, et al. . Psychological burden associated with worse clinical outcomes in sarcoidosis. BMJ Open Respir Res. 2019;6(1):e000467. doi: 10.1136/bmjresp-2019-000467. - DOI - PMC - PubMed
    1. Rossides M, Darlington P, Kullberg S, et al. . Sarcoidosis: epidemiology and clinical insights. J Intern Med. 2023;293(6):668–680. doi: 10.1111/joim.13629. - DOI - PubMed
    1. Israël-Biet D, Bernardinello N, Pastré J, et al. . High-risk sarcoidosis: a focus on pulmonary, cardiac, hepatic and renal advanced diseases, as well as on calcium metabolism abnormalities. Diagnostics (Basel). 2024;14(4):395. doi: 10.3390/diagnostics14040395. - DOI - PMC - PubMed

MeSH terms

Supplementary concepts